BoomRx
BoomRx is a US pharmacy technology platform that aggregates 503A compounding and FDA-registered 503B outsourcing pharmacies into a single fulfillment portal for medical clinics, telehealth operators, med spas, and wellness practices, serving 4,500+ clinics nationwide with proprietary nanoemulsion delivery formulations.
- Company typePrivate
- Founded2025
- HeadquartersGainesville, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What BoomRx does
BoomRx is a US-based pharmacy technology platform launched in July 2025 under parent company WellSync that aggregates prescription sourcing and fulfillment for medical clinics, telehealth operators, med spas, and wellness practices. The company consolidates licensed 503A compounding pharmacies and FDA-registered 503B outsourcing facilities behind a single secure portal, replacing the multi-vendor pharmacy relationships that historically consumed 10–20+ staff hours per week at prescribing clinics. The legal operating entity is Click to Fill, Inc., incorporated in Delaware, with Tampa, Florida as its commercial headquarters.
The core product is a centralized pharmacy portal featuring real-time order tracking, automated patient SMS delivery notifications, transparent in-platform pricing, and EMR integration via REST API plus an embeddable JavaScript ordering module. A proprietary nanoemulsion delivery technology has been applied to oral formulations of semaglutide, tirzepatide, testosterone, and PDE5-inhibitor combination erectile dysfunction therapy, supporting injection-free prescribing across weight loss, hormone replacement, and sexual health. 503B partners provide sterile injectables with extended 90/180/365-day Beyond-Use Dates, and shipments are handled under a flat $30 cold-chain rate to all 50 states and U.S. territories.
Revenue is generated transactionally through per-prescription fulfillment fees plus the flat shipping charge, with claimed pricing approximately 20% below industry averages. Distribution is direct, combining consultative field sales for enterprise telehealth operators with a self-serve web portal and API/EMR integration for multi-location practices. By June 2026, the platform reported more than 4,500 clinics, 40,000+ orders per month at 20% month-over-month growth, an 85% clinic reorder rate, a 2.4% refund rate, and a $70M+ annualized run rate. No third-party institutional funding rounds are disclosed; the company is privately held as a WellSync subsidiary.
BoomRx firmographics
Firmographics- Name
- BoomRx
- Legal name
- Click to Fill, Inc.
- Website
- https://boomrx.com
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BoomRx is a US pharmacy technology platform that aggregates 503A compounding and FDA-registered 503B outsourcing pharmacies into a single fulfillment portal for medical clinics, telehealth operators, med spas, and wellness practices, serving 4,500+ clinics nationwide with proprietary nanoemulsion delivery formulations.
- Ownership category
- akta.pro rank
BoomRx industry classification
Industry- Product category
- Pharmacy Fulfillment Software
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
- akta.pro secondary industries
- Compounding Pharmacy & Sterile Prep Workflow Systems (HLACAKAM), Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH), Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)
Keywords
Where BoomRx is headquartered
LocationHeadquarters
- HQ city
- Gainesville
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
BoomRx business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Prescription Fulfillment Services: BoomRx generates revenue through prescription order processing and fulfillment services to medical clinics and healthcare providers. The platform connects clinics to its pharmacy network and coordinates fulfillment, charging competitive industry pricing with transparent platform pricing and a flat $30 shipping fee. Revenue has grown from $15.5M net order revenue in first 8 months to over $70M annualized run rate.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Transparent pricing with competitive rates |
| Unit Pricing | Pay-as-you-go | One consolidated shipping fee |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
BoomRx product offering
Product offeringCore offering
BoomRx operates a centralized pharmacy portal platform that consolidates prescription sourcing, ordering, and fulfillment across 503A compounding pharmacies, FDA-registered 503B outsourcing facilities, and brand medications through a single secure interface for medical clinics, med spas, telehealth providers, and physician offices. The platform provides 50-state cold chain shipping with a flat $30 fee, real-time order tracking, EMR API integration, automated SMS patient updates, and access to 300+ therapies covering weight loss, peptides, TRT, BHRT, erectile dysfunction, hair loss, and dermatology. The company also applies proprietary nanoemulsion delivery technology to oral formulations of semaglutide, tirzepatide, testosterone, and erectile dysfunction medications.
Product overview
BoomRx is a unified pharmacy technology platform that consolidates prescription sourcing and fulfillment for medical practices, functioning as a single portal replacing multiple pharmacy relationships. The platform provides access to 503A compounding pharmacies, FDA-registered 503B outsourcing facilities, and brand medications through one secure interface. The core offering includes the BoomRx Pharmacy Portal with real-time order tracking and EMR integration capabilities, supporting therapeutic areas including hormone therapy (injectable, topical, and oral HRT/TRT), sexual health (ED therapies), weight management (GLP-1, peptide-based protocols, and oral nanoemulsion medications), peptides and longevity, hair and skin treatments, and general wellness. Add-on modules include oral nanoemulsion formulations of semaglutide, tirzepatide, testosterone, and erectile dysfunction therapies, plus peptide-based skincare products. The platform offers $30 flat-rate cold chain shipping to all 50 states and competitive pricing (20% below industry average).
Differentiator
Problem solved
Functional benefit
Products and services
- BoomRx Pharmacy Portal Unified prescription sourcing and fulfillment platform consolidating multiple pharmacy relationships, portals, and workflows into a single secure interface for physician practices, med spas, telemedicine providers, and wellness clinics. Provides access to 503A compounding pharmacies, FDA-registered 503B outsourcing facilities, and brand medications with 50-state shipping.
- Oral Semaglutide Oral weight management medication utilizing proprietary nanoemulsion delivery technology for enhanced absorption and consistent dosing in GLP-1 based weight loss protocols, available to medical clinics, med spas, wellness practices, and telemedicine providers nationwide.
- Oral Tirzepatide Oral weight management medication utilizing proprietary nanoemulsion delivery technology for enhanced absorption and dose uniformity in GIP/GLP-1 based weight loss protocols, available nationwide for medical clinics, med spas, wellness practices, and telemedicine providers.
- Oral Liquid Testosterone Replacement Therapy (TRT) Injection-free oral liquid testosterone replacement therapy using proprietary nanoemulsion delivery, designed to support telemedicine, med spa, and hybrid practices in expanding TRT services without in-office administration burden.
- Oral Liquid Erectile Dysfunction Therapy Oral liquid erectile dysfunction therapy combining sildenafil, tadalafil, and vardenafil (PDE5 inhibitors) in a proprietary nanoemulsion delivery system, providing an injection-free option for men's sexual health treatment as part of comprehensive wellness care.
- Copper Peptide Skin Repair Cream Peptide-based skincare product centered on GHK-Cu (Copper Tripeptide-1), supporting skin repair, smoother texture, improved firmness, and appearance of youthful, collagen-rich skin. Enables healthcare providers to integrate aesthetic skincare alongside existing therapies.
Quantifiable outcome
- 90%+ reduction in prescription management administrative time
- +5 more outcomes
Companies that use BoomRx
Customer profileNamed customers2 records
Segments5 records
Ideal customer profiles4 records
BoomRx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature6 records
BoomRx partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered supporting and core.
- GooglesupportingBoomRx's platform users are bound by Google's Terms of Service. The platform uses Google Maps API(s) for location services, with further information available in Google's Privacy Policy.
- 503A Compounding PharmaciescoreBoomRx partners with licensed 503A compounding pharmacies operating under section 503A of the Federal Food, Drug, and Cosmetic Act. These pharmacies provide access to compounded preparations for weight management, hormone therapy, peptides, and specialty medications through the centralized portal.
- 503B Outsourcing FacilitiescoreBoomRx partners with FDA-registered 503B outsourcing facilities subject to current Good Manufacturing Practice (cGMP) requirements and FDA inspection. These facilities provide injectable sterile medications with extended Beyond-Use Dates (90, 180, 365 days), supporting longer patient programs and reduced shipping frequency.
Scale indicators12 records
Recent moves6 records
Expansion highlights4 records
BoomRx competitors and assessment
Company assessmentBroad incumbents
- Ro: Telehealth platform with vertically integrated pharmacy operations covering weight management, men's health, and dermatology. Comparable in therapeutic overlap and as a potential consolidator building its own practitioner and pharmacy rails.
- DoseSpot: ePrescribing platform integrated into numerous EMR systems, enabling controlled substance and general prescribing workflows for clinicians. Comparable on the EMR integration and ePrescribing layer, though DoseSpot is workflow rather than fulfillment.
- Hims & Hers Health: Vertically integrated telehealth and pharmacy platform offering weight loss, TRT, ED, and dermatology direct to consumers. Operates in overlapping therapeutic categories and could become a competitor or potential acquirer as it builds practitioner and compounding capabilities.
Direct peers
- Fullscript: Practitioner-facing wellness and pharmacy platform serving integrative and functional medicine clinics with prescription and supplement fulfillment. Directly comparable as a B2B portal aggregating dispensing partners for clinics, though Fullscript leans more toward supplements than compounding pharmacy.
- Capsule Pharmacy: Digital-first pharmacy offering integrated EMR-style ordering and tracking for providers with home delivery to patients. Comparable technology-forward pharmacy model, though consumer-direct rather than B2B clinic portal.
- Alto Pharmacy: Digital pharmacy platform with same-day delivery, real-time tracking, and EMR-integrated ordering for providers and patients. Comparable as a technology-forward pharmacy aggregator, though Alto is consumer-direct rather than practitioner-portal-first like BoomRx.
- Empower Pharmacy: Large 503A and 503B compounding pharmacy serving practitioners nationwide with weight loss, hormone, and peptide therapies. Comparable as a major supplier in the same compounding categories BoomRx aggregates, with overlapping customer base of med spas, telehealth, and clinics.
- SMP Pharmacy Solutions: Compounding pharmacy network providing customized medications for clinics, med spas, and telehealth providers across multiple states. Closely comparable business model as a multi-state compounder serving the same practitioner segments BoomRx targets.
- Belmar Pharma Solutions: National compounding pharmacy network (503A) serving integrative, functional, and anti-aging practitioners with hormone and peptide therapies. Directly comparable as a multi-state compounder targeting the same med spa, wellness, and telehealth customer base.
- AnazaoHealth: 503A and 503B compounding pharmacy specializing in sterile injectables, hormones, and wellness therapies for practitioners. Comparable as a 503B outsourcing facility serving clinics and med spas in categories BoomRx aggregates.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
BoomRx social profiles
Digital presenceBoomRx compliance and trust
Trust signalCompliance3 records
BoomRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
BoomRx leadership team
Management profileNumber of profiles
Profiles3 records
BoomRx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BoomRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BoomRx
What does BoomRx do?
BoomRx operates a centralized pharmacy portal platform that consolidates prescription sourcing, ordering, and fulfillment across 503A compounding pharmacies, FDA-registered 503B outsourcing facilities, and brand medications through a single secure interface for medical clinics, med spas, telehealth providers, and physician offices. The platform provides 50-state cold chain shipping with a flat $30 fee, real-time order tracking, EMR API integration, automated SMS patient updates, and access to 300+ therapies covering weight loss, peptides, TRT, BHRT, erectile dysfunction, hair loss, and dermatology. The company also applies proprietary nanoemulsion delivery technology to oral formulations of semaglutide, tirzepatide, testosterone, and erectile dysfunction medications.
Is BoomRx a public or private company?
BoomRx is a private company. It is classified as corporate owned and is currently operating.
When was BoomRx founded?
BoomRx was founded in 2025. It employs 11 to 50 people.
Where is BoomRx based?
BoomRx is headquartered in Gainesville, United States, in the North America region.
How does BoomRx make money?
One revenue line is on record: prescription Fulfillment Services.
Who are BoomRx's main competitors?
Broad incumbents on record are Ro, DoseSpot and Hims & Hers Health. Direct peers are Fullscript, Capsule Pharmacy, Alto Pharmacy, Empower Pharmacy, SMP Pharmacy Solutions, Belmar Pharma Solutions and AnazaoHealth.
Does BoomRx have an API?
Yes. BoomRx offers API integration that connects clinic EMR systems directly to the BoomRx pharmacy network, enabling automatic prescription order transmission, real-time status updates, and patient data synchronization without manual steps. Additionally, clinics can use a JavaScript module to embed a pre-built ordering interface into their systems.
What industry is BoomRx in?
BoomRx's product category is Pharmacy Fulfillment Software. Its primary akta.pro industry code is HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms, with a secondary code of HLACAKAM, Compounding Pharmacy & Sterile Prep Workflow Systems. Its NAICS code is 42421 and its SIC code is 5122.